|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/08 | (2013.01) |
| A61K 38/08 | (2019.01) | ||
| A61K 31/35 | (2006.01) | ||
| A61K 38/26 | (2013.01) | ||
| A61P 5/00 | (2006.01) | ||
| A61K 38/29 | (2013.01) | ||
| C07K 7/06 | (2006.01) | ||
| A61K 38/07 | (2013.01) | ||
| A61K 47/549 | (2017.08) | ||
| A61P 19/00 | (2018.01) | ||
| A61P 19/08 | (2018.01) | ||
| A61P 19/10 | (2018.01) | ||
| A61P 25/04 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 5/00 | (2018.01) | ||
| A61P 5/18 | (2018.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61K 38/095 | (2019.01) |
| (11) | Number of the document | 2709645 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12784971.9 |
| Date of filing the European patent application | 2012-05-17 | |
| (97) | Date of publication of the European application | 2014-03-26 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/038429 |
| Date | 2012-05-17 |
| (87) | Number | WO 2012/158962 |
| Date | 2012-11-22 |
| (30) | Number | Date | Country code |
| 201161487638 P | 2011-05-18 | US | |
| 201161487636 P | 2011-05-18 | US | |
| 201161543725 P | 2011-10-05 | US | |
| 201161543721 P | 2011-10-05 | US |
| (72) |
NESTOR, John J. , US
|
| (73) |
Eumederis Pharmaceuticals, Inc. ,
12707 High Bluff Drive, Suite 200, San Diego, CA 92130,
US
|
| (54) | IMPROVED PEPTIDE PHARMACEUTICALS |
| IMPROVED PEPTIDE PHARMACEUTICALS |